Profound Medical (PROF) recently announced the FDA clearance of its Contouring Assistant AI module, designed to enhance the creation of automated treatment plans for prostate cancer using its TULSA-PRO system. This clearance marks a major step forward in the field of prostate cancer treatment through the integration of Artificial Intelligence (AI) into prostate cancer procedures, which holds promising implications for both patients and healthcare providers.The Transurethral Ultrasound Ablation (TULSA) proce ...